Levetiracetam Tablet, Film Coated
Product Images NDC 70518-1901

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70518-1901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Levetiracetam 1000 mg film-coated tablets packaging label showing quantity of 30 tablets. The label includes the NDC number 70518-1901-00, manufacturer information as Camber Pharma, Inc., Piscataway, NJ, and directions for use to see package insert. The product is repackaged by RemedyRepack Inc., Indiana, PA. The label features the RemedyRepack logo and states 'RX ONLY'.*

FDA Label Image

Levetiracetam 1000mg 70518 1901 01

Levetiracetam 1000 mg oral tablet film-coated, in a quantity of 30, labeled with the NDC 70518-1901-01. The label includes the manufacturer Camber Pharma, Inc., Piscataway, NJ, and repackager RemedyRepack Inc., Indiana, PA. The label also shows storage instructions and a QR code.*

FDA Label Image

Levetiracetam 1000mg 70518 1901 02

Levetiracetam 1000 mg tablet label, film coated, with quantity of 1 tablet. The label includes the NDC 70518-1901-02 and notes repackaging by RemedyRepack Inc. Directions advise to see package insert and storage temperature guidelines. Manufacturer is Camber Pharma, Inc.*

FDA Label Image

Levefig1

A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day (N=100), and Levetiracetam 3000 mg/day (N=101). The chart shows higher percentages of patients in both Levetiracetam groups compared to placebo.*

FDA Label Image

Levefig2

A bar chart comparing the percentage of patients across three groups: placebo (6.3%, N=111), Levetiracetam 1000 mg/day (20.8%, N=106), and Levetiracetam 2000 mg/day (35.2%, N=105). Each bar is labeled with its respective percentage and sample size.*

FDA Label Image

Levefig3

A bar chart comparing the percentage of patients between two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The chart shows approximately 14.4% of patients in the placebo group and 39.4% in the Levetiracetam group, indicating a notable difference between the two groups.*

FDA Label Image

Levefig4

A bar chart comparing the percentage of patients responding to treatment between Levetiracetam 1000 mg and placebo groups. The vertical axis shows percent of patients, with the Levetiracetam group demonstrating a higher percentage (44.6%) compared to placebo (19.6%). The horizontal axis lists the two groups with respective sample sizes (N=101 for Levetiracetam, N=87 for placebo).*

FDA Label Image

Levefig5

A bar chart comparing the percentage of responders between two groups: Placebo (N=64) and Levetiracetam (N=79). The Levetiracetam group shows a higher response rate of 72.2% compared to 45.2% for the placebo group.*

FDA Label Image

Levefig6

A bar chart comparing the percent reduction in seizures between placebo and Levetiracetam groups. The placebo group shows a 45.2% reduction, while the Levetiracetam group shows a 72.2% reduction, indicating a higher efficacy for Levetiracetam in seizure reduction.*

FDA Label Image

Levestructure

Chemical structure diagram showing the molecular formula of levetiracetam, the active ingredient. The structure includes a pyrrolidone ring and other functional groups consistent with levetiracetam's molecular configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.